Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group study

Structure-antitumor activity relationships among quinone derivatives.

1974 • 85 citations

Treatment of patients with recurrent primary brain tumors with AZQ

1984 • 56 citations

Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.

1982 • 40 citations

Diaziquone (AZQ)

1983 • 35 citations

Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics

1982 • 26 citations

Preliminary communication — Treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ; NSC-182986)

1983 • 12 citations

Preliminary communication — Treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ; NSC-182986)

1983 • 7 citations